Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-b2-glycoprotein I antibodies

L. La Rosa, G. Covini, C. Galperin, L. Catelli, N. Del Papa, G. Reina, A. Morabito, G. Balestrieri, A. Tincani, M. Eric Gershwin, P. L. Meroni

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


The aim of this study was to characterize the antigen specificity and to evaluate the diagnostic and prognostic value of anti-mitochondrial M5 type antibodies (AMA M5). Fifty-eight patients selected on the basis of their AMA M5 positivity were investigated in relationship to their clinical and serological profile. Cross-absorption studies, Western blotting and immunoprecipitation analysis were carried out for AMA M5 antigen specificity characterization. Most patients had a diagnosis of systemic lupus erythematosus (SLE) (65.5%) or of primary anti-phospholipid syndrome (PAPS) (24%); all the patients were positive for IgG or IgM anti-cardiolipin (anti- CL) antibodies and 49% of them also displayed lupus anticoagulant (LA) activity. Anti-β2-glycoprotein I (β2-GPI) IgG were detectable in 30/38 sera (78.9%) and IgM in 34/38 (89.4%). While anti-CL and anti-β2-GPI IgG antibodies were significantly associated with history of thrombosis and fetal loss, AMA M5 displayed a statistical association only for thrombocytopenia and recurrent fetal loss. Absorption with human β2-GPI both in free solution or in solid phase as well as with CL liposomes or CL/β2-GPI liposome complexes did not affect AMA M5 fluorescence. While AMA M5 activity is absorbed by whole mitochondrial preparations, no specific reactivities against several human, bovine and rat mitochondrial proteins could be detected in Western blotting and immunoprecipitation studies. AMA M5 appear to he detectable in both primary and secondary APS, displaying a strong association with the presence of thrombocytopenia and fetal loss. Although strictly related to anti-phospholipid antibodies, AMA M5, anti-CL and anti- β2-GPI antibodies represent distinct serological markers of the APS.

Original languageEnglish (US)
Pages (from-to)144-151
Number of pages8
JournalClinical and Experimental Immunology
Issue number1
StatePublished - 1998


  • Anti-β-glycoprotein I antibodies
  • Anti-mitochondrial M5 antibodies
  • Anti-phospholipid syndrome
  • Fetal loss
  • Thrombocytopenia
  • Thrombosis

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-b<sub>2</sub>-glycoprotein I antibodies'. Together they form a unique fingerprint.

Cite this